Tregs release related factors such as TGF-β and IL-10/35, downregulating anti-tumor immunity and inhibiting antigen presentation by dendritic cells (DCs), further dampening immune responses by lymphocytes (45). This evidence concerns the gene TGFB1 and neoplasm.